192 related articles for article (PubMed ID: 11256023)
41. Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.
McBride NC; Cavenagh JD; Ward MC; Grant I; Schey S; Gray A; Hughes A; Mills MJ; Cervi P; Newland AC; Kelsey SM
Leuk Lymphoma; 2001 Jun; 42(1-2):89-98. PubMed ID: 11699226
[TBL] [Abstract][Full Text] [Related]
42. [DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].
Liu XM; Wang HQ; Zhang HL; Qiu LH; Li W; Li LF; Cui XZ; Liu PF; Hao XS
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):779-82. PubMed ID: 19173813
[TBL] [Abstract][Full Text] [Related]
43. [Clinical study of COAD-B regimen in treatment of patients with relapsed/refractory non-Hodgkin lymphoma].
Li MH; Li YF; Yin QS; Mi RH; Chen L; Du JW; Wei XD
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):857-61. PubMed ID: 24171959
[TBL] [Abstract][Full Text] [Related]
44. Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
Steinke B; Bross K; Reinold HM; Heim ME; Schalk KP; Heidemann E; Josten K; Arnold H; Manegold C; Hoffman I
Eur J Cancer; 1992; 28(1):100-4. PubMed ID: 1373634
[TBL] [Abstract][Full Text] [Related]
45. [Results of the synchronization therapy with vincristine and cyclophosphamide in lymphogranulomatosis, reticulum cell sarcoma and lymphosarcoma. A phase II study (author's transl)].
Klein HO; Gerecke D; Borberg H; Gross R; Hoefer-Janker H; Scheef W; Diehl V; Lohmann E; Adler D; Buter E; Löhning A; Brock N; Burkert H
Dtsch Med Wochenschr; 1975 Aug; 100(35):1719-26. PubMed ID: 1098886
[TBL] [Abstract][Full Text] [Related]
46. [Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)].
Brault P; Gilles E; Ribrag V; Bourhis JH; Munck JN; Pico JL; Hayat M
Bull Cancer; 1995 Dec; 82(12):1032-7. PubMed ID: 8745669
[TBL] [Abstract][Full Text] [Related]
47. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
[TBL] [Abstract][Full Text] [Related]
48. Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
Sanchez-Gonzalez B; Peñalver FJ; Medina A; Guillén H; Calleja M; Gironella M; Arranz R; Sebastian E; de Oña R; Cánovas A; de la Fuente I; Grande C; Sancho JM; Perez R; Domingo E; Lopez-Lorenzo JL; Prieto E; Panizo C; Gorosquieta A; Perez I; Cervera JM; Marin M; Mencha C; Ramila E; Salar A
Leuk Res; 2012 Jun; 36(6):709-14. PubMed ID: 22154023
[TBL] [Abstract][Full Text] [Related]
49. ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
Hänel M; Kröger N; Hoffknecht MM; Peters SO; Metzner B; Fiedler F; Braumann D; Schubert JC; Illiger HJ; Hänel A; Krüger WH; Zeller W; Weh HJ; Hossfeld DK; Zander AR
Ann Hematol; 2000 Jun; 79(6):304-11. PubMed ID: 10901609
[TBL] [Abstract][Full Text] [Related]
50. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia.
Kath R; Blumenstengel K; Fricke HJ; Höffken K
J Cancer Res Clin Oncol; 2001 Jan; 127(1):48-54. PubMed ID: 11206271
[TBL] [Abstract][Full Text] [Related]
51. A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas.
Cheson BD; Crawford J
Br J Haematol; 2015 May; 169(4):528-33. PubMed ID: 25752751
[TBL] [Abstract][Full Text] [Related]
52. NOPE for relapsed aggressive diffuse non-Hodgkin's lymphoma.
Bezwoda WR; Bezwoda MA; Seymour L; Dansey R; Ariad S
Leuk Lymphoma; 1993 Jul; 10(4-5):329-33. PubMed ID: 8220131
[TBL] [Abstract][Full Text] [Related]
53. [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].
Tigges FJ; Schmülling RM; Hiller E; Waller HD; Wilms K
Dtsch Med Wochenschr; 1977 Oct; 102(43):1537-41. PubMed ID: 334504
[TBL] [Abstract][Full Text] [Related]
54. Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
Sarris AH; Hagemeister F; Romaguera J; Rodriguez MA; McLaughlin P; Tsimberidou AM; Medeiros LJ; Samuels B; Pate O; Oholendt M; Kantarjian H; Burge C; Cabanillas F
Ann Oncol; 2000 Jan; 11(1):69-72. PubMed ID: 10690390
[TBL] [Abstract][Full Text] [Related]
55. Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.
Limmer S; Eberle N; Nerschbach V; Nolte I; Betz D
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():21-31. PubMed ID: 24548273
[TBL] [Abstract][Full Text] [Related]
56. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
Robak T; Smolewski P; Urbanska-Rys H; Gora-Tybor J; Blonski JZ; Kasznicki M
Leuk Lymphoma; 2004 May; 45(5):937-44. PubMed ID: 15291352
[TBL] [Abstract][Full Text] [Related]
57. Bendamustine: something old, something new.
Tageja N; Nagi J
Cancer Chemother Pharmacol; 2010 Aug; 66(3):413-23. PubMed ID: 20376452
[TBL] [Abstract][Full Text] [Related]
58. Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Kim H; Kang HJ; Lee JW; Park JD; Park KD; Shin HY; Ahn HS
Childs Nerv Syst; 2013 Oct; 29(10):1851-8. PubMed ID: 23748464
[TBL] [Abstract][Full Text] [Related]
59. Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
Espeli V; Ruegg E; Hottinger AF; Modarressi A; Dietrich PY
Anticancer Res; 2016 May; 36(5):2359-64. PubMed ID: 27127144
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
Fosså SD; Droz JP; Stoter G; Kaye SB; Vermeylen K; Sylvester R
Br J Cancer; 1995 Mar; 71(3):619-24. PubMed ID: 7880748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
